Alzheimer's enzyme important for myelin

An enzyme involved in Alzheimer's disease also contributes to myelination of peripheral nerves, according to a study in this week in Science. Inhibitors of this enzyme, called beta-Secretase, are considered to be prime candidates for Alzheimer's treatment, so the enzyme's role in myelination may have implications for potential side effects of these drugs, the authors say."It's a mild cautionary note to those who are developing the beta-secretase drugs," said Robert Vassar of Northwestern University in Evanston, Ill., who was not involved in the study.In Alzheimer's disease, amyloid beta (Aß) peptide accumulates in the brain. A beta-secretase enzyme called BACE1 (ß-site APP cleaving enzyme-1) is required for Aß synthesis; in BACE knockout mice, no Aß peptide is produced .Although BACE1's role in Alzheimer's is fairly well-established, not much is known about the enzyme's possible role in normal physiology, said study senior author Christian Haass of Ludwig-Maximilians-University in Münich. Led by Michael Willem, also of Ludwig-Maximilians-University, the researchers found that BACE1 expression is highest in postnatal mice when neurons are becoming coated in myelin. The researchers also found that the pattern of BACE1 expression in the peripheral nervous system is very similar to that of neuregulin 1, a factor uknown to be important for myelination.Using electron microscopy, the researchers found that the myelin surrounding the peripheral nerves in BACE1 knockouts is abnormally thin. They also found that unprocessed neuregulin 1 accumulates in BACE1 knockout animals, indicating that BACE1 is likely required for neuregulin 1 to myelinate axons normally.Based on these results, "BACE clearly plays a very important role in development, particularly in controlling the myelin sheath thickness," said Philip Wong of Johns Hopkins University in Baltimore, who was not involved in the study. The finding "came as a big surprise to all of us," Haass told The Scientist in an email.Since Aß peptides cannot be synthesized in the absence of beta-secretase activity, many researchers are hopeful that inhibitors of beta-secretases may be effective in treating Alzheimer's disease. Beta-secretase inhibitors blocking nerve myelination should not be a problem in adult patients, Wong said, as long as BACE1 is not responsible for maintenance of the myelin sheath. It's possible that a problem could arise if a patient taking beta-secretase inhibitors for Alzheimer's disease sustained a peripheral nerve injury, Vassar said. Based on the study's findings, the drugs might prevent injured nerves from repairing myelin. "It's something to be aware of" when beta-secretase inhibitors are tested in clinical trials, Vassar said, "but I don't think it's a big red flag." Melissa Lee Phillips
mphillips@the-scientist.comLinks within this articleD. Steinberg, "Testing Potential Alzheimer Vaccines," The Scientist, January 21, 2002. http://www.sciencemag.orgE. Russo, "The Search for Secretases," The Scientist, November 8, 1999. http://www.the-scientist.com/1999/11/08/7/1J.B. Weitzman, "Mining myelination," The Scientist, June 27, 2002. 'http://www.the-scientist.com/article/display/20487Robert Vassar http://www.cmb.northwestern.edu/faculty/robert_vassar.htmH. Cai et al., "BACE1 is the major beta-secretase for generation of Abeta peptides by neurons," Nature Neuroscience, March 2001. http://www.the-scientist.com/pubmed/11056475Christian Haass http://haass.web.med.uni-muenchen.deMichael Willem http://haass.web.med.uni-muenchen.de/willem.htmlA.N. Garratt et al., "Neuregulin, a factor with many functions in the life of a schwann cell," Bioessays, November 2000. http://www.the-scientist.com/pubmed/11056475Philip Wong http://www.hopkinsmedicine.org/graduateprograms/cmm/wong.htmlR. Vassar et al., "The beta-secretase, BACE: a prime drug target for Alzheimer's disease," Journal of Molecular Neuroscience, October 2001. http://www.the-scientist.com/pubmed/11816789

Alzheimer's enzyme important for myelin

The Scientist ARCHIVES

Become a Member of

Meet the Author

Melissa Lee Phillips

Related Research Resources

What Is the Amniotic Fluid Composed of?

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Advancing Drug Discovery with Complex Human In Vitro Models

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Maximizing Cancer Research Model Systems

Products

Product News

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform